N
Naomi B. Swiezy
Researcher at Indiana University
Publications - 53
Citations - 5115
Naomi B. Swiezy is an academic researcher from Indiana University. The author has contributed to research in topics: Autism & Risperidone. The author has an hindex of 29, co-authored 53 publications receiving 4579 citations. Previous affiliations of Naomi B. Swiezy include Kennedy Krieger Institute & Indiana University – Purdue University Indianapolis.
Papers
More filters
Journal ArticleDOI
Risperidone in Children with Autism and Serious Behavioral Problems
James T. McCracken,James J. McGough,Bhavik Shah,Pegeen Cronin,Daniel Hong,Michael G. Aman,L. Eugene Arnold,Ronald L. Lindsay,Patricia L. Nash,Jill A. Hollway,Christopher J. McDougle,David J. Posey,Naomi B. Swiezy,Arlene E. Kohn,Lawrence Scahill,Andrés Martin,Kathleen Koenig,Fred R. Volkmar,Deirdre H. Carroll,Allison Lancor,Allison Lancor,Elaine Tierney,Jaswinder K. Ghuman,N. González,Marco A. Grados,Benedetto Vitiello,Louise Ritz,Mark Davies,James Robinson,Donald J. McMahon +29 more
TL;DR: Risperidone was effective and well tolerated for the treatment of tantrums, aggression, or self-injurious behavior in children with autistic disorder and the benefit was maintained at six months.
Journal ArticleDOI
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity
David J. Posey,David J. Posey,Michael G. Aman,L. Eugene Arnold,Yaser Ramadan,Andrea N. Witwer,Ronald L. Lindsay,Christopher J. McDougle,Naomi B. Swiezy,Arlene E. Kohn,James T. McCracken,Bhavik Shah,Pegeen Cronin,James J. McGough,Lisa Sea Yun Lee,Lawrence Scahill,Andrés Martin,Kathleen Koenig,Deirdre H. Carroll,Christopher Young,Allison Lancor,Elaine Tierney,Jaswinder K. Ghuman,N. González,Marco A. Grados,Benedetto Vitiello,Louise Ritz,Shirley Chuang,Mark Davies,James Robinson,Donald J. McMahon +30 more
TL;DR: Methylphenidate was often efficacious in treating hyperactivity associated with pervasive developmental disorders, but the magnitude of response was less than that seen in typically developing children with attention-deficit/hyperactivity disorder.
Journal ArticleDOI
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
Christopher J. McDougle,Lawrence Scahill,Michael G. Aman,James T. McCracken,Elaine Tierney,Mark Davies,L. Eugene Arnold,David J. Posey,Andrã¨s Martin,Jaswinder K. Ghuman,Bhavik Shah,Shirley Chuang,Naomi B. Swiezy,N. González,Jill A. Hollway,Kathleen Koenig,James J. McGough,Louise Ritz,Benedetto Vitiello +18 more
TL;DR: Risperidone led to significant improvements in the restricted, repetitive, and stereotyped patterns of behavior, interests, and activities of autistic children but did not significantly change their deficit in social interaction and communication.
Journal ArticleDOI
Effect of Parent Training vs Parent Education on Behavioral Problems in Children With Autism Spectrum Disorder: A Randomized Clinical Trial
Karen Bearss,Cynthia R. Johnson,Cynthia R. Johnson,Tristram Smith,Luc Lecavalier,Naomi B. Swiezy,Michael G. Aman,David B. McAdam,Eric Butter,Charmaine Stillitano,Noha Minshawi,Denis G. Sukhodolsky,Daniel W. Mruzek,Kylan Turner,Tiffany J. Neal,Victoria Hallett,James A. Mulick,Bryson Green,Benjamin L. Handen,Yanhong Deng,James Dziura,Lawrence Scahill +21 more
TL;DR: For children with autism spectrum disorder, a 24-week parent training program was superior to parent education for reducing disruptive behavior on parent-reported outcomes, although the clinical significance of the improvement is unclear.
Journal ArticleDOI
Medication and Parent Training in Children with Pervasive Developmental Disorders and Serious Behavior Problems: Results from a Randomized Clinical Trial.
Michael G. Aman,Christopher J. McDougle,Lawrence Scahill,Benjamin L. Handen,L. Eugene Arnold,Cynthia R. Johnson,Kimberly A. Stigler,Karen Bearss,Eric Butter,Naomi B. Swiezy,Denis D. Sukhodolsky,Yaser Ramadan,Stacie L. Pozdol,Roumen Nikolov,Luc Lecavalier,Arlene E. Kohn,Kathleen Koenig,Jill A. Hollway,Patricia Korzekwa,Allison Gavaletz,James A. Mulick,Kristy L. Hall,James Dziura,Louise Ritz,Stacie Trollinger,Sunkyung Yu,Benedetto Vitiello,Ann Wagner +27 more
TL;DR: Medication plus PT resulted in greater reduction of serious maladaptive behavior than MED in children with PDDs, with a lower risperidone dose.